CRISPR Therapeutics AG (CRSP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1239546,
    "name": "CRISPR Therapeutics AG",
    "stock_name": "CRISPR Therapeutics AG",
    "full_name": "CRISPR Therapeutics AG",
    "name_url": "stocks-analysis/crispr-therapeutics-ag",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "58.18",
    "chg": 6.6,
    "chgp": "12.8%",
    "dir": 1,
    "prev_price": "51.58",
    "mcapval": "4,930.17",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "CH0334081137",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.8 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/crispr-therapeutics-ag-1239546-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "CRISPR Therapeutics Hits Day Low at $48.24 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crispr-therapeutics-hits-day-low-at-4824-amid-price-pressure-3721569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CRISPRTherapeut_priceRelatedfactors_3721569.png",
        "date": "2025-11-21 16:19:02",
        "description": "CRISPR Therapeutics AG faced notable stock volatility on November 20, 2025, declining significantly while the S&P 500 gained modestly. The company reported a substantial drop in net sales and continued losses over the past quarters, reflecting ongoing financial challenges within the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "CRISPR Therapeutics Hits Day High with 8.24% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crispr-therapeutics-hits-day-high-with-824-surge-in-stock-price-3712576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CRISPRTherapeut_priceRelatedfactors_3712576.png",
        "date": "2025-11-18 17:27:25",
        "description": "CRISPR Therapeutics AG's stock surged today, contrasting with a slight decline in the S&P 500. While the company has seen modest weekly gains, its monthly performance has dipped. Despite challenges like low return on equity and recent financial losses, it has outperformed the S&P 500 over the past year."
      },
      {
        "title": "CRISPR Therapeutics Hits Day Low of $54.91 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crispr-therapeutics-hits-day-low-of-5491-amid-price-pressure-3676147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CRISPRTherapeut_priceRelatedfactors_3676147.png",
        "date": "2025-11-06 16:19:48",
        "description": "CRISPR Therapeutics AG's stock fell significantly today, reflecting ongoing challenges for the company. Despite a positive annual return, its long-term performance shows a notable decline. Financial metrics indicate low profitability, with consecutive quarterly losses and a substantial drop in net sales, while the company faces a challenging financial landscape."
      },
      {
        "title": "Is CRISPR Therapeutics AG technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crispr-therapeutics-ag-technically-bullish-or-bearish-3673698",
        "imagepath": "",
        "date": "2025-11-05 11:22:59",
        "description": "As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a positive outlook. While the Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames, the daily moving averages show a mildly bullish trend. However, the KST and Dow Theory present a mixed picture, with weekly signals being mildly bearish and monthly signals bullish. \n\nThe stock has underperformed the S&P 500 over the past week and month, with returns of -14.17% and -16.73% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. Despite this recent underperformance, the year-to-date return of 43.32% significantly outpaces the S&P 500's 16.30%. Overall, the current technical stance is bullish, albeit with some caution due to mixed indicators...."
      },
      {
        "title": "Is CRISPR Therapeutics AG technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crispr-therapeutics-ag-technically-bullish-or-bearish-3670877",
        "imagepath": "",
        "date": "2025-11-04 11:34:37",
        "description": "As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Daily moving averages indicate a bullish stance. However, the KST and Dow Theory show mixed signals with weekly readings being mildly bearish and monthly readings mildly bullish. The Bollinger Bands are mildly bullish for both weekly and monthly periods, and the OBV is mildly bullish as well. \n\nIn terms of returns, CRISPR has underperformed the S&P 500 over the last week and month, with returns of -5.71% and -8.52% respectively, while year-to-date and one-year returns are strong at 57.44% and 22.08%, outperforming the S&P 500's 16.30% and 19.89%. Overall, the current technical stance is bullish, reflecting a strengthening trend despite some mixed indicators...."
      },
      {
        "title": "Is CRISPR Therapeutics AG technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crispr-therapeutics-ag-technically-bullish-or-bearish-3666482",
        "imagepath": "",
        "date": "2025-11-03 11:34:21",
        "description": "As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the KST and Dow Theory show mixed signals with the weekly readings being mildly bearish. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, while the OBV is mildly bullish as well.\n\nIn terms of performance, the stock has returned 62.58% year-to-date and 37.94% over the past year, significantly outperforming the S&P 500, which returned 16.30% and 19.89% respectively during the same periods. Overall, the current technical stance is bullish, with moderate strength indicated by the mixed signals from some indicators...."
      },
      {
        "title": "Is CRISPR Therapeutics AG technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crispr-therapeutics-ag-technically-bullish-or-bearish-3664596",
        "imagepath": "",
        "date": "2025-11-02 11:18:48",
        "description": "As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages are also bullish, indicating strong upward momentum. However, the KST and Dow Theory on a weekly basis show mildly bearish signals, which suggests some caution is warranted. The stock has underperformed the S&P 500 over the past week and month, with returns of -5.35% and -3.28%, respectively, compared to the S&P 500's gains of 0.71% and 1.92%. Despite this recent weakness, the year-to-date return of 62.58% significantly outperforms the S&P 500's 16.30%, indicating strong longer-term performance. Overall, the current stance is bullish, with strength primarily driven by the daily moving averages and weekly MACD...."
      },
      {
        "title": "CRISPR Therapeutics Hits Day Low of $64.80 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crispr-therapeutics-hits-day-low-of-6480-amid-price-pressure-3641346",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CRISPRTherapeut_priceRelatedfactors_3641346.png",
        "date": "2025-10-23 17:38:11",
        "description": "CRISPR Therapeutics AG's stock fell significantly today, contrasting with the S&P 500's stability. Despite a strong yearly performance, the company has faced challenges, including negative results over the past four quarters, a substantial decline in net sales, and low profitability indicators."
      },
      {
        "title": "CRISPR Therapeutics Hits Day High with 8.72% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crispr-therapeutics-hits-day-high-with-872-surge-in-stock-price-3608137",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CRISPRTherapeut_priceRelatedfactors_3608137.png",
        "date": "2025-10-09 21:00:54",
        "description": "CRISPR Therapeutics AG's stock surged on October 8, 2025, achieving an intraday high and outperforming the S&P 500. Despite impressive short-term gains and significant year-to-date growth, the company faces challenges, including low return on equity and declining net sales and profits over the past year."
      }
    ],
    "total": 18,
    "sid": "1239546",
    "stock_news_url": "https://www.marketsmojo.com/news/crispr-therapeutics-ag-1239546"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

CRISPR Therapeutics Hits Day Low at $48.24 Amid Price Pressure

2025-11-21 16:19:02

CRISPR Therapeutics AG faced notable stock volatility on November 20, 2025, declining significantly while the S&P 500 gained modestly. The company reported a substantial drop in net sales and continued losses over the past quarters, reflecting ongoing financial challenges within the pharmaceuticals and biotechnology sector.

CRISPR Therapeutics Hits Day High with 8.24% Surge in Stock Price

2025-11-18 17:27:25

CRISPR Therapeutics AG's stock surged today, contrasting with a slight decline in the S&P 500. While the company has seen modest weekly gains, its monthly performance has dipped. Despite challenges like low return on equity and recent financial losses, it has outperformed the S&P 500 over the past year.

CRISPR Therapeutics Hits Day Low of $54.91 Amid Price Pressure

2025-11-06 16:19:48

CRISPR Therapeutics AG's stock fell significantly today, reflecting ongoing challenges for the company. Despite a positive annual return, its long-term performance shows a notable decline. Financial metrics indicate low profitability, with consecutive quarterly losses and a substantial drop in net sales, while the company faces a challenging financial landscape.

Is CRISPR Therapeutics AG technically bullish or bearish?

2025-11-05 11:22:59

As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a positive outlook. While the Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames, the daily moving averages show a mildly bullish trend. However, the KST and Dow Theory present a mixed picture, with weekly signals being mildly bearish and monthly signals bullish. The stock has underperformed the S&P 500 over the past week and month, with returns of -14.17% and -16.73% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. Despite this recent underperformance, the year-to-date return of 43.32% significantly outpaces the S&P 500's 16.30%. Overall, the current technical stance is bullish, albeit with some caution due to mixed indicators....

Is CRISPR Therapeutics AG technically bullish or bearish?

2025-11-04 11:34:37

As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Daily moving averages indicate a bullish stance. However, the KST and Dow Theory show mixed signals with weekly readings being mildly bearish and monthly readings mildly bullish. The Bollinger Bands are mildly bullish for both weekly and monthly periods, and the OBV is mildly bullish as well. In terms of returns, CRISPR has underperformed the S&P 500 over the last week and month, with returns of -5.71% and -8.52% respectively, while year-to-date and one-year returns are strong at 57.44% and 22.08%, outperforming the S&P 500's 16.30% and 19.89%. Overall, the current technical stance is bullish, reflecting a strengthening trend despite some mixed indicators....

Is CRISPR Therapeutics AG technically bullish or bearish?

2025-11-03 11:34:21

As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the KST and Dow Theory show mixed signals with the weekly readings being mildly bearish. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, while the OBV is mildly bullish as well. In terms of performance, the stock has returned 62.58% year-to-date and 37.94% over the past year, significantly outperforming the S&P 500, which returned 16.30% and 19.89% respectively during the same periods. Overall, the current technical stance is bullish, with moderate strength indicated by the mixed signals from some indicators....

Is CRISPR Therapeutics AG technically bullish or bearish?

2025-11-02 11:18:48

As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages are also bullish, indicating strong upward momentum. However, the KST and Dow Theory on a weekly basis show mildly bearish signals, which suggests some caution is warranted. The stock has underperformed the S&P 500 over the past week and month, with returns of -5.35% and -3.28%, respectively, compared to the S&P 500's gains of 0.71% and 1.92%. Despite this recent weakness, the year-to-date return of 62.58% significantly outperforms the S&P 500's 16.30%, indicating strong longer-term performance. Overall, the current stance is bullish, with strength primarily driven by the daily moving averages and weekly MACD....

CRISPR Therapeutics Hits Day Low of $64.80 Amid Price Pressure

2025-10-23 17:38:11

CRISPR Therapeutics AG's stock fell significantly today, contrasting with the S&P 500's stability. Despite a strong yearly performance, the company has faced challenges, including negative results over the past four quarters, a substantial decline in net sales, and low profitability indicators.

CRISPR Therapeutics Hits Day High with 8.72% Surge in Stock Price

2025-10-09 21:00:54

CRISPR Therapeutics AG's stock surged on October 8, 2025, achieving an intraday high and outperforming the S&P 500. Despite impressive short-term gains and significant year-to-date growth, the company faces challenges, including low return on equity and declining net sales and profits over the past year.

View All News